These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 667828)

  • 1. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P; Connelly K; Cerna I; Mandel HG
    Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the antitumor action of 5-fluorouracil (FU).
    Mandel HG; Klubes P; Fernandes DJ
    Bull Cancer; 1979; 66(1):49-54. PubMed ID: 420946
    [No Abstract]   [Full Text] [Related]  

  • 3. A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
    Fernandes DJ; Klubes P
    Cancer Res; 1979 Apr; 39(4):1396-404. PubMed ID: 421224
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 5-fluorouracil on human colon carcinoma and solid rat Walker 256 carcinosarcoma: evaluation as in vitro predictors of clinical response.
    Klubes P; Cerna I; Connelly K; Geelhoed GW; Mandel HG
    Cancer Treat Rep; 1978 Jul; 62(7):1065-73. PubMed ID: 688247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 6. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM; Danhauser L; Wang G
    Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
    Bruckner HW; Schreiber C; Waxman S
    Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased formation of 5-fluoro-2'-deoxyuridine 5'-monophosphate from 5-fluorouracil in the presence of 2-deoxy-alpha-D-ribose 1-phosphate and 2'-deoxyuridine in Ehrlich ascites tumor cells.
    Tamemasa O; Tezuka M
    Nucleic Acids Symp Ser; 1980; (8):s169-72. PubMed ID: 7255189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 10. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Rogers WI
    Cancer Res; 1972 May; 32(5):1045-56. PubMed ID: 4259631
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
    Rustum YM; Danhauser L; Luccioni C; Au JL
    Cancer Treat Rep; 1981; 65 Suppl 3():73-82. PubMed ID: 7049369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)].
    Mattern J; Volm M; Wayss K; Weber N
    Arzneimittelforschung; 1980; 30(6):981-4. PubMed ID: 6774738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.
    Hopkins HA; Kovacs CJ; Looney WB; Wakefield JA
    Cancer Biochem Biophys; 1976; 1(6):303-12. PubMed ID: 189899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.
    Ardalan B; Buscaglia MD; Schein PS
    Biochem Pharmacol; 1978; 27(16):2009-13. PubMed ID: 718724
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
    Tanaka M; Kimura K; Yoshida S
    Cancer Res; 1983 Nov; 43(11):5145-50. PubMed ID: 6225512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemic cells and Walker tumor cells.
    Chang JC; Hall TC
    Oncology; 1973; 28(3):232-7. PubMed ID: 4767109
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism for exclusion of 5-fluorouracil from DNA.
    Ingraham HA; Tseng BY; Goulian M
    Cancer Res; 1980 Apr; 40(4):998-1001. PubMed ID: 6101994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil.
    Washtien WL; Santi DV
    Cancer Res; 1979 Sep; 39(9):3397-404. PubMed ID: 157805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.